
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
Hippocrates

Accurate cannabinoid isomer identification is a critical requirement in both forensic toxicology and the emerging field of medicinal cannabis. While the therapeutic use of compounds like cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) grows, the ability to distinguish these structural isomers remains technically demanding. Traditional methods often struggle with thermal instability or identical spectral profiles. This can lead to potential misidentification in legal and clinical settings.
For decades, Gas Chromatography-Electron Ionization-Mass Spectrometry (GC-EI-MS) has been the gold standard for analysis. However, the high temperatures in the GC inlet can cause thermal degradation. Furthermore, it often converts acidic cannabinoids into their neutral forms. In contrast, Liquid Chromatography-Mass Spectrometry (LC-MS) offers a gentler approach. However, even with electrospray ionization (ESI), structural isomers like THC and CBD often yield nearly identical product ion spectra. This similarity significantly reduces the effectiveness of cannabinoid isomer identification using standard tandem mass spectrometry (MS/MS).
Recent research introduces a transformative approach using copper (Cu) salts to induce molecular ion formation. By introducing Cu ions under ESI conditions, analysts can create unique molecular complexes. These copper-cannabinoid adducts exhibit fragmentation patterns similar to electron ionization spectra but without the thermal risks. Additionally, this method allows for the differentiation of thirteen different cannabinoids by producing characteristic ions that act as chemical fingerprints. Therefore, this approach provides a more reliable analytical pathway.
This alternative workflow aligns with the needs of drug analysts and clinicians who require high-confidence data. The generated spectra can be searched against established EI-MS libraries, such as the NIST library. Moreover, the successful application of this technique to real-world cannabis plant extracts demonstrates its robustness. For healthcare providers, these advancements ensure that prescribed cannabinoid products meet strict purity standards. Consequently, patients receive medications that are free from illicit or unintended isomers.
Differentiation is essential because isomers like THC and CBD have vastly different legal statuses and pharmacological effects. Misidentification can lead to incorrect dosing or legal complications for patients and providers.
Copper ions help form unique molecular complexes that fragment into distinct "fingerprint" ions. This allows mass spectrometers to see differences between molecules that otherwise look identical under standard testing conditions.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or legal guidance regarding the use of cannabinoids. Refer to the latest local and national guidelines for clinical practice.
References
Couch AN et al. Differentiation of cannabinoid isomers via Cu-mediated molecular ion formation and electrospray ionization-tandem mass spectrometry. J Forensic Sci. 2026 Mar 08. doi: 10.1111/1556-4029.70290. PMID: 41796083.
Couch AN, Zall CM, Davidson JT. Differentiation of CBD and Δ9-THC isomers using copper-ion complexation and electrospray ionization-tandem mass spectrometry. Anal Chim Acta. 2026 Jan 22;1384:344953. doi: 10.1016/j.aca.2025.344953.
Pichini S, et al. Analysis of Cannabinoids in Biological Specimens: An Update. Toxics. 2020;8(1):7. doi: 10.3390/toxics8010007.

Researchers have developed a new Cu-mediated ESI-MS/MS method to differentiate cannabinoid isomers, offering a highly accurate alternative to traditional GC...
3 months ago

A nationwide French survey highlights the evolving landscape of venous thromboembolism management, with DOACs becoming the standard of care while LMWH remains essential for high-risk and cancer-associated cases. The results emphasize a shift toward outpatient PE management and dose-tapering strategies.
Today

A recent 20-year retrospective analysis reveals that uterine cancer survival disparities are deeply influenced by socioeconomic factors such as education and income, alongside clinical indicators like age and tumor grade. The study emphasizes the need for enhanced patient support and early diagnosis.
Today

Researchers have introduced a gradient-microstructure synergy strategy to create self-powered ionic skins. These devices achieve ultrahigh sensitivity, enabling the real-time detection of subtle physiological signals and human motions without the need for external power sources.
Today

MRI-based quantification of fatty acid composition in the knee shows high repeatability for PDFF and SFA at 3T, while PUFA remains more variable. This technology offers a non-invasive way to study the role of lipids in musculoskeletal diseases like osteoarthritis.
Today

A recent study demonstrates that integrating clinical phenotype, pedigree data, and AI-driven tools like AlphaMissense can reclassify 70% of MEN1 variants of uncertain significance. This approach provides actionable diagnostic clarity, facilitating better surveillance and family testing for hereditary syndromes.
Today